AgomAb Therapeutics NV Statistics
NASDAQ: AGMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
5.45-0.17 (-3.02%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AgomAb Therapeutics NV by the numbers
AgomAb Therapeutics NV has a market capitalization of $268.4 million based on 49.25M shares outstanding. With trailing EPS of $-2.08, AgomAb Therapeutics NV is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.3% below its 50-day average and 53.4% below its 200-day average.
Average daily trading volume is 208.99K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AGMB valuation vs. peer median
| Metric | AGMB | Peer median | Difference |
|---|---|---|---|
| Market cap | $268.40M | $258.70M | +4% |
| Avg. volume | 208.99K | 886.23K | -76% |
Peer median across 8 companies: KYTX, AGEN, OCGN, EIKN, DTIL, SABS, EDIT, LXEO.
Valuation
- Market cap
- $268.40M
- EPS (TTM)
- $-2.08
- Shares outstanding
- 49.25M
Price and trading
- Previous close
- 5.62
- Open
- 5.51
- Day range
- 5.39 – 5.78
- 52-week range
- 5.39 – 17.82
- Beta
- —
- Volume
- 188.94K
- Average volume
- 208.99K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 268.40M
- Forward Pe
- -2.70
- Eps
- -2.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.82
- Week52 Low
- 5.39
- Avg Volume
- 208.99K
- Shares Outstanding
- 49.25M
- Ma50
- 8.70
- Ma200
- 11.69
- Pct From52w High
- -69.42%
- Pct From52w Low
- 1.11%